# Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers

> **NCT04863105** · PHASE1 · COMPLETED · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 36 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Abiraterone acetate tablets(Zecke ®250 mg);Abiraterone acetate tablets(250 mg)

## Key facts

- **NCT ID:** NCT04863105
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-24
- **Primary completion:** 2017-12-25
- **Final completion:** 2018-04-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04863105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04863105, "Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04863105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*